Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03054961|
Recruitment Status : Recruiting
First Posted : February 16, 2017
Last Update Posted : April 24, 2019
|Condition or disease||Intervention/treatment|
|Epilepsies, Partial||Device: Near-infrared spectroscopy|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study - MULTICHANNEL NIRS for Epilepsy Seizure Detection|
|Actual Study Start Date :||February 10, 2017|
|Estimated Primary Completion Date :||February 9, 2022|
|Estimated Study Completion Date :||February 9, 2024|
Near-infrared spectroscopy for subjects with partial (focal) epilepsy seizures being studied in the EMU.
Device: Near-infrared spectroscopy
Measurement of CCO redox state and cerebral oxygenation during epileptic seizures.
- Change in CCO redox state and oxygen saturation [ Time Frame: 1 week ]Regional cerebral saturation of oxygen and/or cytochrome oxidase redox state will change prior, during, and after onset of seizure activity when compared to non-seizure side of brain.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03054961
|Contact: Harry T Whelan, MDfirstname.lastname@example.org|
|United States, Wisconsin|
|The Medical College of Wisconsin||Recruiting|
|Milwaukee, Wisconsin, United States, 53226|
|Contact: Harry T Whelan, MD 414-266-7540 email@example.com|
|Principal Investigator:||Harry T Whelan, MD||Medical College of Wisconsin|